These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 10748702

  • 21. Eighteen months of drug treatment for depression: predicting relapse and recovery.
    Mulder RT, Frampton CM, Luty SE, Joyce PR.
    J Affect Disord; 2009 Apr; 114(1-3):263-70. PubMed ID: 18805590
    [Abstract] [Full Text] [Related]

  • 22. [Clinical characteristics and typological classification of endogenous depression resistant to treatment].
    Bondar' VV.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992 Apr; 92(1):84-8. PubMed ID: 1319660
    [Abstract] [Full Text] [Related]

  • 23. Virchow-Robin space dilatation may predict resistance to antidepressant monotherapy in elderly patients with depression.
    Patankar TF, Baldwin R, Mitra D, Jeffries S, Sutcliffe C, Burns A, Jackson A.
    J Affect Disord; 2007 Jan; 97(1-3):265-70. PubMed ID: 16919335
    [Abstract] [Full Text] [Related]

  • 24. New approaches to managing difficult-to-treat depressions.
    Thase ME.
    J Clin Psychiatry; 2003 Jan; 64 Suppl 1():3-4. PubMed ID: 12625798
    [Abstract] [Full Text] [Related]

  • 25. Serotonin precursors in the treatment of depression.
    van Praag HM.
    Adv Biochem Psychopharmacol; 1982 Jan; 34():259-86. PubMed ID: 6753514
    [Abstract] [Full Text] [Related]

  • 26. [Serotonin precursors as antidepressive agents: a review].
    Beckmann H, Kasper S.
    Fortschr Neurol Psychiatr; 1983 May; 51(5):176-82. PubMed ID: 6603403
    [Abstract] [Full Text] [Related]

  • 27. Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
    Pålhagen SE, Carlsson M, Curman E, Wålinder J, Granérus AK.
    Acta Neurol Scand; 2008 May; 117(5):295-304. PubMed ID: 18279483
    [Abstract] [Full Text] [Related]

  • 28. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls.
    Neumeister A, Nugent AC, Waldeck T, Geraci M, Schwarz M, Bonne O, Bain EE, Luckenbaugh DA, Herscovitch P, Charney DS, Drevets WC.
    Arch Gen Psychiatry; 2004 Aug; 61(8):765-73. PubMed ID: 15289275
    [Abstract] [Full Text] [Related]

  • 29. Clinical features of treatment-resistant depression.
    Kornstein SG, Schneider RK.
    J Clin Psychiatry; 2001 Aug; 62 Suppl 16():18-25. PubMed ID: 11480880
    [Abstract] [Full Text] [Related]

  • 30. Chronic buspirone treatment normalizes regional serotonin synthesis in the olfactory bulbectomized rat brain: an autoradiographic study.
    Watanabe A, Hasegawa S, Nishi K, Nguyen KQ, Diksic M.
    Brain Res Bull; 2006 Mar 31; 69(2):101-8. PubMed ID: 16533657
    [Abstract] [Full Text] [Related]

  • 31. [Pharmacokinetic factors and resistance to antidepressant treatment].
    Vandel B, Vandel S.
    Encephale; 1986 Oct 31; 12 Spec No():217-22. PubMed ID: 3545788
    [Abstract] [Full Text] [Related]

  • 32. [Plasma tryptophan in a protein controlled diet in depressed patients].
    Candito M, Aubin-Brunet V, Tonelli I, Feuillade P, Pringuey D, Chambon P, Darcourt G.
    Encephale; 1994 Oct 31; 20(3):327-32. PubMed ID: 8088236
    [Abstract] [Full Text] [Related]

  • 33. Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study.
    Olfson M, Marcus SC, Shaffer D.
    Arch Gen Psychiatry; 2006 Aug 31; 63(8):865-72. PubMed ID: 16894062
    [Abstract] [Full Text] [Related]

  • 34. [Drug resistance in endogenous depression Part II. Refractoriness to antidepressants in affective disorders].
    Puzyński S, Koszewska I, Kalinowski A, Bogdanowicz E, Swiecicki L.
    Psychiatr Pol; 1994 Aug 31; 28(1):5-15. PubMed ID: 8190818
    [Abstract] [Full Text] [Related]

  • 35. [Erythrocyte membrane transport of L-tyrosine and L-tryptophan in 66 patients with depressive syndromes. Preliminary results].
    Pringuey D, Bovier P, Chiaroni P, Widmer J, Dufour H, Gaillard JM, Tissot R.
    Acta Psychiatr Belg; 1986 Aug 31; 86(2):131-40. PubMed ID: 3728058
    [Abstract] [Full Text] [Related]

  • 36. [Changes in the kinetics of erythrocyte membrane transport of tryptophan in depression].
    Jeanningros R, Grignon S, Giusiano B, Tissot R.
    Encephale; 1989 Aug 31; 15(2):251-4. PubMed ID: 2752958
    [Abstract] [Full Text] [Related]

  • 37. Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism.
    Russo S, Kema IP, Haagsma EB, Boon JC, Willemse PH, den Boer JA, de Vries EG, Korf J.
    Psychosom Med; 2005 Aug 31; 67(5):773-7. PubMed ID: 16204437
    [Abstract] [Full Text] [Related]

  • 38. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.
    Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR.
    Arch Gen Psychiatry; 1990 May 31; 47(5):411-8. PubMed ID: 2184795
    [Abstract] [Full Text] [Related]

  • 39. [Plasma amino acid disturbances and depression].
    Mathis P, Schmitt L, Benatia M, Granier F, Ghisolfi J, Moron P.
    Encephale; 1988 May 31; 14(2):77-82. PubMed ID: 3391131
    [Abstract] [Full Text] [Related]

  • 40. [Refractory depression: therapeutic alternatives].
    López-Ibor Aliño JJ, Chinchilla A, Vega M, Sánchez P, Camarero M, Jordá L, Viñas R, Moreno I.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1989 May 31; 17(4):223-30. PubMed ID: 2801264
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.